Endovascular Treatment of a Persistent Sciatic Artery Aneurysm Complicated by Lower Extremity Arterial Embolism

View at publisher
Authors: Wenfei Guan, Peng Jiang, Yongpan Cui, Zihan Zhang, Jian He, Kewei Wang, Jianfeng Sun, Fei Mei
Cited by: 0
References: 21

Abstract

Persistent sciatic artery (PSA) is a rare congenital vascular abnormality associated with the embryonic development of the iliac, common femoral, and superficial femoral arteries. Most cases of PSA are incidentally detected and are generally asymptomatic. However, PSA can present as chronic pain, such as neuralgia from aneurysmal dilatation compressing the sciatic nerve, or ischemic pain due to thrombus embolization from the aneurysm. In severe cases, aneurysm rupture poses a significant threat to both limb and life. Timely detection and appropriate intervention are therefore crucial. This article explores the clinical characteristics and treatment strategies of PSA, exemplified through the management of a patient with PSA complicated by distal embolization.Clinical ImpactThis study underscores the importance of simultaneously addressing both the aneurysm and distal thromboembolism in symptomatic persistent sciatic artery (PSA) cases, rather than treating embolic events alone. It reinforces endovascular repair as a preferred, minimally invasive strategy, reducing surgical trauma and nerve injury risk. For clinicians, this highlights the need for vigilant follow-up and consideration of early combined intervention to prevent recurrence. The innovation lies in demonstrating the efficacy of a staged, hybrid endovascular approach and proposing postural modification as a potential adjunct to slow aneurysm progression, offering a refined management paradigm for this rare condition.

Fields of Study & Subjects

Vascular anomalies and interventions Aortic aneurysm repair treatments Abdominal vascular conditions and treatments

Publication details

Journal / source
Journal of Endovascular Therapy
Pages
15266028261417148–15266028261417148
Publication date
30 January 2026
Language
EN